Abstract
The invention provides an agent for modulating the activity of CLEC14A for the use in treating and/or preventing osteopenia and/or osteoporosis.
| Original language | English |
|---|---|
| IPC | WO 2021/069890 A1 |
| Publication status | Published - 15 Apr 2021 |
Research output: Patent
| Original language | English |
|---|---|
| IPC | WO 2021/069890 A1 |
| Publication status | Published - 15 Apr 2021 |